Cargando…
Adhesion Molecules, Altered Vasoreactivity, and Brain Atrophy in Type 2 Diabetes
OBJECTIVE: To investigate the effects of inflammation on perfusion regulation and brain volumes in type 2 diabetes. RESEARCH DESIGN AND METHODS: A total of 147 subjects (71 diabetic and 76 nondiabetic, aged 65.2 ± 8 years) were studied using 3T anatomical and continuous arterial spin labeling magnet...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198286/ https://www.ncbi.nlm.nih.gov/pubmed/21926285 http://dx.doi.org/10.2337/dc11-0969 |
_version_ | 1782214406766067712 |
---|---|
author | Novak, Vera Zhao, Peng Manor, Brad Sejdić, Ervin Alsop, David Abduljalil, Amir Roberson, Paula K. Munshi, Medha Novak, Peter |
author_facet | Novak, Vera Zhao, Peng Manor, Brad Sejdić, Ervin Alsop, David Abduljalil, Amir Roberson, Paula K. Munshi, Medha Novak, Peter |
author_sort | Novak, Vera |
collection | PubMed |
description | OBJECTIVE: To investigate the effects of inflammation on perfusion regulation and brain volumes in type 2 diabetes. RESEARCH DESIGN AND METHODS: A total of 147 subjects (71 diabetic and 76 nondiabetic, aged 65.2 ± 8 years) were studied using 3T anatomical and continuous arterial spin labeling magnetic resonance imaging. Analysis focused on the relationship between serum soluble vascular and intercellular adhesion molecules (sVCAM and sICAM, respectively, both markers of endothelial integrity), regional vasoreactivity, and tissue volumes. RESULTS: Diabetic subjects had greater vasoconstriction reactivity, more atrophy, depression, and slower walking. Adhesion molecules were specifically related to gray matter atrophy (P = 0.04) and altered vasoreactivity (P = 0.03) in the diabetic and control groups. Regionally, sVCAM and sICAM were linked to exaggerated vasoconstriction, blunted vasodilatation, and increased cortical atrophy in the frontal, temporal, and parietal lobes (P = 0.04–0.003). sICAM correlated with worse functionality. CONCLUSIONS: Diabetes is associated with cortical atrophy, vasoconstriction, and worse performance. Adhesion molecules, as markers of vascular health, have been indicated to contribute to altered vasoregulation and atrophy. |
format | Online Article Text |
id | pubmed-3198286 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-31982862012-11-01 Adhesion Molecules, Altered Vasoreactivity, and Brain Atrophy in Type 2 Diabetes Novak, Vera Zhao, Peng Manor, Brad Sejdić, Ervin Alsop, David Abduljalil, Amir Roberson, Paula K. Munshi, Medha Novak, Peter Diabetes Care Original Research OBJECTIVE: To investigate the effects of inflammation on perfusion regulation and brain volumes in type 2 diabetes. RESEARCH DESIGN AND METHODS: A total of 147 subjects (71 diabetic and 76 nondiabetic, aged 65.2 ± 8 years) were studied using 3T anatomical and continuous arterial spin labeling magnetic resonance imaging. Analysis focused on the relationship between serum soluble vascular and intercellular adhesion molecules (sVCAM and sICAM, respectively, both markers of endothelial integrity), regional vasoreactivity, and tissue volumes. RESULTS: Diabetic subjects had greater vasoconstriction reactivity, more atrophy, depression, and slower walking. Adhesion molecules were specifically related to gray matter atrophy (P = 0.04) and altered vasoreactivity (P = 0.03) in the diabetic and control groups. Regionally, sVCAM and sICAM were linked to exaggerated vasoconstriction, blunted vasodilatation, and increased cortical atrophy in the frontal, temporal, and parietal lobes (P = 0.04–0.003). sICAM correlated with worse functionality. CONCLUSIONS: Diabetes is associated with cortical atrophy, vasoconstriction, and worse performance. Adhesion molecules, as markers of vascular health, have been indicated to contribute to altered vasoregulation and atrophy. American Diabetes Association 2011-11 2011-10-15 /pmc/articles/PMC3198286/ /pubmed/21926285 http://dx.doi.org/10.2337/dc11-0969 Text en © 2011 by the American Diabetes Association. https://creativecommons.org/licenses/by-nc-nd/3.0/Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ (https://creativecommons.org/licenses/by-nc-nd/3.0/) for details. |
spellingShingle | Original Research Novak, Vera Zhao, Peng Manor, Brad Sejdić, Ervin Alsop, David Abduljalil, Amir Roberson, Paula K. Munshi, Medha Novak, Peter Adhesion Molecules, Altered Vasoreactivity, and Brain Atrophy in Type 2 Diabetes |
title | Adhesion Molecules, Altered Vasoreactivity, and Brain Atrophy in Type 2 Diabetes |
title_full | Adhesion Molecules, Altered Vasoreactivity, and Brain Atrophy in Type 2 Diabetes |
title_fullStr | Adhesion Molecules, Altered Vasoreactivity, and Brain Atrophy in Type 2 Diabetes |
title_full_unstemmed | Adhesion Molecules, Altered Vasoreactivity, and Brain Atrophy in Type 2 Diabetes |
title_short | Adhesion Molecules, Altered Vasoreactivity, and Brain Atrophy in Type 2 Diabetes |
title_sort | adhesion molecules, altered vasoreactivity, and brain atrophy in type 2 diabetes |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198286/ https://www.ncbi.nlm.nih.gov/pubmed/21926285 http://dx.doi.org/10.2337/dc11-0969 |
work_keys_str_mv | AT novakvera adhesionmoleculesalteredvasoreactivityandbrainatrophyintype2diabetes AT zhaopeng adhesionmoleculesalteredvasoreactivityandbrainatrophyintype2diabetes AT manorbrad adhesionmoleculesalteredvasoreactivityandbrainatrophyintype2diabetes AT sejdicervin adhesionmoleculesalteredvasoreactivityandbrainatrophyintype2diabetes AT alsopdavid adhesionmoleculesalteredvasoreactivityandbrainatrophyintype2diabetes AT abduljalilamir adhesionmoleculesalteredvasoreactivityandbrainatrophyintype2diabetes AT robersonpaulak adhesionmoleculesalteredvasoreactivityandbrainatrophyintype2diabetes AT munshimedha adhesionmoleculesalteredvasoreactivityandbrainatrophyintype2diabetes AT novakpeter adhesionmoleculesalteredvasoreactivityandbrainatrophyintype2diabetes |